Portal de Periódicos da CAPES

Artigo Acesso aberto Produção Nacional Revisado por pares

BIBTEX RIS

Blockade of CTLA-4 promotes the development of effector CD8+ T lymphocytes and the therapeutic effect of vaccination with an attenuated protozoan expressing NY-ESO-1

2014; Springer Science+Business Media; Volume: 64; Issue: 3 Linguagem: Inglês

10.1007/s00262-014-1634-8

1432-0851

Luara Isabela dos Santos, Bruno Galvão-Filho, Paula Cristina de Faria, Caroline Junqueira, Míriam Santos Dutra, Santuza Maria Ribeiro Teixeira, Maurício M. Rodrigues, Gerd Ritter, Oliver Bannard, Douglas T. Fearon, Lis Ribeiro do Valle Antonelli, Ricardo T. Gazzinelli,

T-cell and B-cell Immunology

The development of cancer immunotherapy has long been a challenge. Here, we report that prophylactic vaccination with a highly attenuated Trypanosoma cruzi strain expressing NY-ESO-1 (CL-14-NY-ESO-1) induces both effector memory and effector CD8+ T lymphocytes that efficiently prevent tumor development. However, the therapeutic effect of such a vaccine is limited. We also demonstrate that blockade of Cytotoxic T Lymphocyte Antigen 4 (CTLA-4) during vaccination enhances the frequency of NY-ESO-1-specific effector CD8+ T cells producing IFN-γ and promotes lymphocyte migration to the tumor infiltrate. As a result, therapy with CL-14-NY-ESO-1 together with anti-CTLA-4 is highly effective in controlling the development of an established melanoma.